PALM BEACH GARDENS, Fla. — October 10, 2025 — Leads & Copy — ZimVie Inc. (Nasdaq: ZIMV) announced that at the special meeting of ZimVie stockholders held on October 10, 2025, the ZimVie stockholders voted to approve the acquisition of ZimVie by an affiliate of ARCHIMED pursuant to the terms and conditions of the Agreement and Plan of Merger, dated as of July 20, 2025.
The parties now expect the Merger to close on October 20, 2025, subject to the satisfaction of all conditions in the Merger Agreement.
ZimVie is a global life sciences leader in the dental implant market that develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. From its headquarters in Palm Beach Gardens, Florida, and additional facilities around the globe, ZimVie works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including trusted dental implants, biomaterials, and digital workflow solutions.
ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Animal & Environmental Health, Biopharma Products, Consumer Health, Diagnostics, Healthcare IT, Life Science Tools & Biologic Services, MedTech, and Pharma Services.
Grace Flowers • Grace.Flowers@ZimVie.com
(561) 319-6130
Webb Campbell • Webb@gilmartinir.com
Source: ZimVie
